Several epidemiological studies have examined the role of acetylcholine in diseases such as Alzheimer's disease (AD), myasthenia gravis, and Parkinson's disease. These studies often focus on the levels of acetylcholine and its receptors in affected individuals, as well as the impact of medications that alter acetylcholine levels.
